ANI Pharmaceuticals Inc. Watch

from 8-K 46 pages 1,898,735 Shares of Common Stock ANI Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 48 pages 1,500,000 Shares of Common Stock ANI Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 49 pages 3.00% Convertible Senior Notes Due 2019 ANI Pharmaceuticals, Inc. Underwriting Agreement December 4, 2014

from 8-K 26 pages 1,402,525 Shares ANI Pharmaceuticals, Inc. Common Stock Underwriting Agreement

from 8-K 16 pages Confidential

from 8-K 38 pages 16,000,000 Shares Biosante Pharmaceuticals, Inc. Common Stock, $0.0001 Par Value Per Share Underwriting Agreement

from 8-K 16 pages Confidential

from 8-K 16 pages Confidential

from 8-K 18 pages Confidential

from 8-K 18 pages Confidential

from SC 13G/A 1 page Pursuant to Rule 13d-1(k) Under the Securities Exchange Act of 1934, the Undersigned Hereby Agree That Only One Statement Containing the Information Required on Amendment No. 9 to Schedule 13g Need Be Filed With Respect to Ownership by Each of the Undersigned of Shares of Common Stock of Biosante Pharmaceuticals, Inc. This Agreement May Be Executed in Any Number of Counterparts, Each of Which Shall Be Deemed an Original. Dated: February 4, 2010 /S/ Ross J. Mangano Ross J. Mangano Jo & Co By: /S/ Ross J. Mangano Ross J. Mangano Its: President 1

from 8-K 17 pages Confidential

from SC 13G/A 1 page Pursuant to Rule 13d-1(k) Under the Securities Exchange Act of 1934, the Undersigned Hereby Agree That Only One Statement Containing the Information Required on Amendment No. 8 to Schedule 13g Need Be Filed With Respect to Ownership by Each of the Undersigned of Shares of Common Stock of Biosante Pharmaceuticals, Inc. This Agreement May Be Executed in Any Number of Counterparts, Each of Which Shall Be Deemed an Original. Dated: February 1, 2009 /S/ Ross J. Mangano Ross J. Mangano Jo & Co By: /S/ Ross J. Mangano Ross J. Mangano Its: President 1

from SC 13G/A 1 page Pursuant to Rule 13d-1(k) Under the Securities Exchange Act of 1934, the Undersigned Hereby Agree That Only One Statement Containing the Information Required on Amendment No. 7 to Schedule 13g Need Be Filed With Respect to Ownership by Each of the Undersigned of Shares of Common Stock of Biosante Pharmaceuticals, Inc. This Agreement May Be Executed in Any Number of Counterparts, Each of Which Shall Be Deemed an Original. Dated: February 13, 2008 /S/ Ross J. Mangano Ross J. Mangano Jo & Co By: S/ Ross J. Mangano Ross J. Mangano Its: President

from SC 13G/A 1 page Pursuant to Rule 13d-1(f)(1) Under the Securities Exchange Act of 1934, the Undersigned Hereby Agree That Only One Statement Containing the Information Required on Amendment No. 6 to Schedule 13g Need Be Filed With Respect to Ownership by Each of the Undersigned of Shares of Common Stock of Biosante Pharmaceuticals, Inc. This Agreement May Be Executed in Any Number of Counterparts, Each of Which Shall Be Deemed an Original. Dated: February 1, 2007 /S/ Ross J. Mangano Ross J. Mangano Jo & Co By: /S/ Ross J. Mangano Ross J. Mangano Its: President Oliver & Co. By: /S/ Ross J. Mangano Ross J. Mangano Its: President